7-Week Integrative Oncology Program | Now Accepting New Patients

Acral Lentiginous Melanoma: Understanding this Skin Cancer

Welcome to our comprehensive guide on acral lentiginous melanoma. This rare but aggressive type of skin cancer can be difficult to detect and diagnose, making it all the more important to understand its characteristics, symptoms, and treatment options.

In section 1, we’ll introduce you to acral lentiginous melanoma, its epidemiology, and the typical ways it manifests. We’ll also explore how doctors diagnose this type of melanoma and what to expect in terms of treatment.

Types of Skin Cancer

Skin cancer is a broad term used to describe a range of cancerous growths that occur in the skin. The three most common types of skin cancer are cutaneous melanoma, basal cell carcinoma, and squamous cell carcinoma.

Cutaneous Melanoma

Cutaneous melanoma is a type of skin cancer that arises from the melanocytes, the cells responsible for producing melanin, the pigment that gives color to the skin, hair, and eyes. It typically appears as a pigmented lesion on the skin, and can be categorized into four subtypes:

Subtype Characteristics
Superficial spreading melanoma The most common type of cutaneous melanoma, which usually appears on the trunk or legs and spreads slowly over time.
Nodular melanoma A rapidly growing subtype of cutaneous melanoma that usually appears as a dark-colored nodule on the skin.
Lentigo maligna melanoma A subtype of cutaneous melanoma that typically occurs in older individuals on sun-exposed skin, such as the face and neck.
Acral lentiginous melanoma A rare subtype of cutaneous melanoma that most commonly affects the hands, feet, and nails.

Basal Cell Carcinoma

Basal cell carcinoma is the most common type of skin cancer, accounting for approximately 80% of all cases. It arises in the basal cells, which are the bottom layer of the epidermis, and usually appears as a pearly or waxy bump on the skin. Although it can grow and invade surrounding tissues, basal cell carcinoma rarely spreads to other parts of the body.

Squamous Cell Carcinoma

Squamous cell carcinoma is the second most common type of skin cancer, accounting for approximately 16% of all cases. It arises in the squamous cells, which are the flat cells that make up the middle layer of the epidermis, and usually appears as a scaly or crusty sore on the skin. Although squamous cell carcinoma is less likely to spread than cutaneous melanoma, it can still be locally aggressive and may cause disfigurement or functional impairment if left untreated.

What is Acral Lentiginous Melanoma?

Acral lentiginous melanoma (ALM) is a rare but aggressive type of skin cancer that arises from the melanocytes, the cells responsible for producing melanin, the pigment that gives color to the skin, hair, and eyes. ALM most commonly affects the hands, feet, and nails, and accounts for approximately 5% of all diagnosed melanomas. Unlike other subtypes of melanoma, ALM is not associated with UV radiation exposure, and is more commonly diagnosed in people with darker skin tones.

ALM is characterized by the appearance of pigmented lesions on the skin that can be flat or slightly raised. These lesions may be brown or black in color, and may have irregular borders or asymmetrical shapes. Patients may also experience non-healing sores, changes in the color or texture of the skin, and other symptoms. ALM can be difficult to diagnose, as it often mimics other skin conditions. A biopsy is required to confirm the presence of cancerous growths.

There are several subtypes of melanoma, including nodular, superficial spreading, and lentigo maligna. ALM is a subtype of melanoma that differs from these other subtypes in terms of its location, appearance, and behavior. As with other forms of melanoma, early detection and treatment are critical to achieving the best possible outcome for patients with ALM.

Signs and Symptoms of Acral Lentiginous Melanoma

The main symptom of acral lentiginous melanoma is the appearance of pigmented lesions on the hands, feet, and nails. These lesions may be flat or raised, and they tend to have irregular borders and variations in color. They may also be accompanied by other symptoms, such as:

  • Non-healing sores
  • Bleeding or oozing from the lesion
  • Inflammation or swelling in the affected area
  • Pain or tenderness in the lesion or nearby skin
  • Changes in the texture or thickness of the skin

In some cases, acral lentiginous melanoma may also cause changes in the nail, such as discoloration, ridges, or thickening. These symptoms may develop slowly over time, or they may appear suddenly.

If you notice any of these symptoms, it is important to seek medical attention right away. While these symptoms may not necessarily indicate melanoma, it is always better to be safe than sorry.

Causes and Risk Factors for Acral Lentiginous Melanoma

Acral lentiginous melanoma is a rare type of skin cancer that typically occurs on the palms of the hands, soles of the feet, and under the nails. The exact cause of this type of melanoma is unknown, but several risk factors have been identified that can increase a person’s likelihood of developing the disease.

UV Radiation

Exposure to ultraviolet (UV) radiation from the sun or tanning beds is a known risk factor for many types of skin cancer, including acral lentiginous melanoma. Although this type of melanoma is less directly linked to UV radiation than other forms of skin cancer, studies have shown that prolonged exposure to the sun’s rays can increase the risk of developing it.

Genetics

Like many other types of cancer, acral lentiginous melanoma can run in families. People with a family history of melanoma are at a higher risk of developing the disease themselves, especially if they have close relatives who have been diagnosed with the disease.

Age and Ethnicity

Acral lentiginous melanoma is more commonly diagnosed in older adults, particularly those over the age of 50. Additionally, certain ethnic groups are more likely to develop this type of melanoma, including people of African, Asian, and Hispanic descent.

Other Risk Factors

Other factors that may increase a person’s risk of developing acral lentiginous melanoma include:

  • Having a weakened immune system, such as from an organ transplant or HIV/AIDS
  • Exposure to chemicals, such as arsenic
  • Having a history of other types of skin cancer
  • Having certain types of moles or pigmented lesions on the skin

If you have any of these risk factors, it’s important to talk to your healthcare provider about ways to lower your risk of developing acral lentiginous melanoma.

Diagnosis of Acral Lentiginous Melanoma

Accurate diagnosis of acral lentiginous melanoma involves several tests and procedures to confirm the presence of this type of melanoma. Diagnosis is essential to ensure that the appropriate treatment is administered promptly. The following diagnostic tools are typically used to confirm a diagnosis:

Skin Biopsy

A skin biopsy involves removing a small sample of skin tissue for examination under a microscope. This test is crucial in determining if a skin lesion is cancerous or benign. There are several biopsy techniques, including shave biopsy, punch biopsy, and excisional biopsy. An experienced healthcare professional will evaluate which biopsy technique is most appropriate for each individual case.

Dermoscopy

Dermoscopy is a non-invasive diagnostic tool that provides an enhanced view of the skin lesions. This method involves using a dermatoscope, a handheld device with a magnifying lens and a bright light, to examine the skin for signs of melanoma. Dermoscopy helps healthcare professionals evaluate the shape, size, and color of the pigmented lesions and identify any irregularities that may indicate skin cancer.

Imaging Tests

If acral lentiginous melanoma is suspected, imaging tests may be ordered to determine the extent of the disease, such as ultrasound, CT scan, MRI or PET scan. These tests use various methods, including sound waves and magnetic fields, to produce images of the inside of the body. These images help healthcare professionals identify the location and size of the tumors, as well as whether or not they have spread to other parts of the body.

In some cases, a lymph node biopsy may be required to determine if the cancer has spread to the lymph nodes. This procedure involves removing a small sample of lymph node tissue and examining it under a microscope. The biopsy can help determine the spread of cancer cells and inform the treatment options.

Stages of Acral Lentiginous Melanoma

Acral lentiginous melanoma is typically classified into stages based on the TNM system, which takes into account several factors to determine the severity of the disease. The TNM system uses three key measures to evaluate the stage of melanoma:

T N M
Size and depth of the primary tumor Involvement of nearby lymph nodes Presence of distant metastases

Based on these measures, acral lentiginous melanoma can be classified into four stages:

  1. Stage 0: This is the earliest stage of acral lentiginous melanoma, where the cancer cells are confined to the top layer of the skin and have not yet invaded deeper tissues. At this stage, the tumor is highly curable with surgery.
  2. Stage I: At this stage, the tumor has grown slightly deeper into the skin, but has not yet spread to nearby lymph nodes or other parts of the body. Surgery is the primary treatment for stage I acral lentiginous melanoma.
  3. Stage II: At this stage, the tumor has spread to nearby lymph nodes, but has not yet metastasized to other parts of the body. Depending on the extent of lymph node involvement, surgery may be combined with radiation therapy or immunotherapy.
  4. Stage III and IV: In these stages, the cancer has spread to other parts of the body, such as the lungs, liver, or brain. Treatment options for stage III and IV acral lentiginous melanoma may include surgery, radiation therapy, chemotherapy, immunotherapy, or a combination of these therapies.

The prognosis for acral lentiginous melanoma varies widely depending on the stage of the disease at diagnosis. Patients with early-stage melanoma have a much higher chance of survival than those with advanced-stage melanoma. Therefore, it is essential to seek medical attention as soon as possible if you notice any suspicious skin lesions.

Treatment Options for Acral Lentiginous Melanoma

The treatment options for acral lentiginous melanoma depend on many factors, including the stage of the cancer, the location of the tumor, the patient’s overall health, and the patient’s preferences. The main treatment options for acral lentiginous melanoma include:

Treatment Description
Surgery Surgery is the most common treatment for acral lentiginous melanoma. The goal of surgery is to remove the tumor and any surrounding tissue that may contain cancer cells. In some cases, amputation of the affected digit or limb may be necessary.
Radiation therapy Radiation therapy uses high-energy radiation to kill cancer cells. It may be used before or after surgery to shrink a tumor or to kill any remaining cancer cells.
Immunotherapy Immunotherapy is a type of treatment that uses the body’s immune system to fight cancer. It works by boosting the immune system’s ability to recognize and attack cancer cells. There are several types of immunotherapy drugs that may be used to treat acral lentiginous melanoma.
Chemotherapy Chemotherapy uses drugs to kill cancer cells. It may be used to treat advanced acral lentiginous melanoma that has spread to other parts of the body.

Surgical Treatment for Acral Lentiginous Melanoma

If surgery is used to treat acral lentiginous melanoma, the type of surgery will depend on the size and location of the tumor. In some cases, a wide excision may be performed, which involves removing the tumor and a margin of healthy tissue around it. In other cases, a sentinel lymph node biopsy may be performed to determine if the cancer has spread to nearby lymph nodes. If the cancer has spread, a lymphadenectomy may be performed to remove the affected lymph nodes.

Radiation Therapy for Acral Lentiginous Melanoma

Radiation therapy may be used to treat acral lentiginous melanoma that cannot be completely removed with surgery or that has spread to other parts of the body. Radiation therapy may also be used after surgery to kill any remaining cancer cells. There are several types of radiation therapy, including external beam radiation therapy and brachytherapy. The type of radiation therapy used will depend on the size and location of the tumor.

Immunotherapy for Acral Lentiginous Melanoma

Immunotherapy is a type of treatment that uses drugs to help the body’s immune system recognize and attack cancer cells. There are several types of immunotherapy drugs that may be used to treat acral lentiginous melanoma. These drugs include checkpoint inhibitors, which block proteins that prevent the immune system from attacking cancer cells, and interleukin-2, which helps stimulate the growth and activity of immune cells.

Chemotherapy for Acral Lentiginous Melanoma

Chemotherapy is a type of treatment that uses drugs to kill cancer cells. It may be used to treat acral lentiginous melanoma that has spread to other parts of the body. Chemotherapy is usually administered intravenously or orally, and the drugs used will depend on the individual case of melanoma.

Prognosis and Survival Rates for Acral Lentiginous Melanoma

The prognosis for acral lentiginous melanoma depends on many factors, including the stage of the melanoma, the size and depth of the tumor, and the presence of metastases. Generally, the earlier the melanoma is diagnosed and treated, the better the prognosis is.

The five-year survival rate for acral lentiginous melanoma ranges from 37% to 65% depending on the stage of the disease. The survival rate for stage I melanoma is high, with an average five-year survival rate of 90%. However, the survival rate for stage IV melanoma is much lower, with an average five-year survival rate of less than 20%.

It is important to note that survival rates are based on large groups of people and do not predict the outcome for individual patients. Some patients with advanced melanoma may respond well to treatment and have better-than-expected survival rates, while others with early-stage melanoma may have a poorer prognosis due to other factors.

Factors That Affect Prognosis

Several factors can affect the prognosis for patients with acral lentiginous melanoma, including:

  • The stage of the melanoma
  • The depth of the tumor
  • The presence of ulceration
  • The patient’s age and overall health
  • Whether the melanoma has spread to nearby lymph nodes or other parts of the body
  • The genetic makeup of the melanoma

It is important for patients to discuss their individual prognosis with their healthcare team, as each case is unique.

Preventing Acral Lentiginous Melanoma

Preventing acral lentiginous melanoma involves taking steps to reduce your exposure to risk factors that can increase the likelihood of developing this type of skin cancer. By protecting your skin and avoiding known risk factors, you can lower your overall risk of developing acral lentiginous melanoma and other types of skin cancer.

UV Protection

One of the most important ways to prevent acral lentiginous melanoma is to protect your skin from UV radiation. This can involve wearing protective clothing, such as hats and long sleeves, and using sunscreen with a high SPF rating. It is also important to avoid prolonged exposure to the sun during peak hours, which are typically between 10 am and 4 pm.

Self-Examination

Performing regular self-examinations of your skin can help you to detect any changes or abnormalities early on, before they develop into cancerous growths. This involves checking your hands, feet, and nails for any irregularities, such as lumps, bumps, or changes in color or texture. If you notice anything unusual, it is important to seek medical attention right away.

Avoiding Risk Factors

Avoiding known risk factors for acral lentiginous melanoma can also help to reduce your overall risk of developing this condition. This can include avoiding exposure to harmful chemicals, such as industrial solvents and pesticides, and quitting smoking if you are a smoker. It is also important to maintain a healthy diet and lifestyle, and to avoid excessive alcohol consumption.

Coping with Acral Lentiginous Melanoma

Receiving a diagnosis of acral lentiginous melanoma can be a stressful and overwhelming experience for both patients and their loved ones. Coping with a serious illness like skin cancer requires a proactive approach that involves both physical and emotional self-care.

Seeking Emotional Support

One of the most important ways to cope with a diagnosis of acral lentiginous melanoma is to seek emotional support from others. This can involve talking to family members, friends, or a mental health professional about your feelings and concerns. Support groups for people with melanoma can also be a valuable source of comfort and advice.

It’s important to remember that it’s normal to feel a range of emotions when dealing with a serious illness, including fear, anger, sadness, and anxiety. Don’t be afraid to express these feelings and reach out for help when you need it.

Maintaining a Positive Outlook

Although a diagnosis of acral lentiginous melanoma can be difficult to cope with, it’s important to maintain a positive outlook and focus on the things that you can control. This can involve setting realistic goals for yourself, staying physically active, and engaging in activities that you enjoy.

Remember that having melanoma does not define who you are as a person, and that you have the ability to live a fulfilling and meaningful life despite your diagnosis. Some people find it helpful to practice mindfulness techniques or meditation to help them stay focused on the present moment and reduce stress levels.

Making Lifestyle Changes

Living with acral lentiginous melanoma may require you to make some changes to your lifestyle to manage your symptoms and improve your overall well-being. This can involve eating a healthy diet, getting regular exercise, and reducing your exposure to UV radiation by wearing protective clothing and sunscreen.

If you are experiencing pain or discomfort, it’s important to talk to your healthcare provider about ways to manage these symptoms. They may be able to prescribe medication or recommend other treatments that can help alleviate your discomfort.

Living with Acral Lentiginous Melanoma

Living with acral lentiginous melanoma can be challenging, both physically and emotionally. However, there are several strategies that can help you manage the symptoms and side effects of the disease, and maintain a good quality of life.

Managing Symptoms

One of the key ways to manage the symptoms of acral lentiginous melanoma is to work closely with your healthcare team to develop a personalized treatment plan. This may include surgery, radiation therapy, immunotherapy, or chemotherapy, depending on the stage and severity of your melanoma.

In addition to medical treatment, there are several self-care strategies that can help alleviate the physical symptoms of acral lentiginous melanoma. These may include:

  • Taking pain medication as prescribed by your doctor
  • Eating a healthy, balanced diet
  • Getting regular exercise
  • Getting enough rest and sleep
  • Using relaxation techniques, such as meditation or yoga, to reduce stress

Improving Quality of Life

Acral lentiginous melanoma can also have a significant impact on your emotional well-being. It is important to take steps to maintain a positive outlook, even in the face of a challenging diagnosis.

One way to do this is to stay connected with friends and loved ones who can provide emotional support. You may also benefit from participating in a support group for people with melanoma, where you can share your experiences and learn from others who are going through similar challenges.

Taking time for yourself and engaging in activities that you enjoy can also help improve your quality of life. This may include hobbies, exercise, or spending time outdoors in a safe and sun-protected environment.

Ongoing Medical Care

Finally, it is important to stay engaged with your healthcare team and to attend all follow-up appointments to monitor the progression of your melanoma. This can help ensure that any new symptoms or changes in your condition are detected early and treated promptly.

By taking a proactive approach to managing your symptoms and maintaining a positive outlook, you can improve your overall quality of life and successfully manage acral lentiginous melanoma.

Section 13: Clinical Trials for Acral Lentiginous Melanoma

Clinical trials play a vital role in advancing the treatment of acral lentiginous melanoma and other types of cancer. These trials test new therapies and treatments that may improve outcomes for patients with this condition.

Experimental treatments may include new drugs, vaccines, or other types of therapies that have not yet been approved by regulatory agencies. Clinical trials must follow strict protocols and guidelines to ensure patient safety and ethical conduct.

Phase 1 Trials

Phase 1 trials test the safety and dosage of new treatments in a small group of patients. These trials aim to determine the best dose of a new therapy and any potential side effects.

If you are considering participating in a clinical trial, talk to your doctor or healthcare provider to determine if you are eligible, and what the potential risks and benefits are.

Phase 2 Trials

Phase 2 trials test the effectiveness of a new therapy in a larger group of patients, typically several dozen to several hundred. These trials aim to determine if a new therapy is effective in treating the condition being studied.

It’s important to note that not all patients who participate in clinical trials will receive the experimental treatment. Some patients may receive a placebo or a standard treatment as a control group.

Phase 3 Trials

Phase 3 trials test the effectiveness of a new therapy in an even larger group of patients, typically several hundred to several thousand. These trials aim to confirm the effectiveness of a new therapy and compare it to the current standard of care.

Finding Clinical Trials

If you are interested in participating in a clinical trial for acral lentiginous melanoma, talk to your doctor or healthcare provider first. They can help you find trials that may be suitable for you and provide information on the potential risks and benefits.

You can also search for clinical trials online through websites such as ClinicalTrials.gov, which is maintained by the U.S. National Institutes of Health.

It’s important to carefully review the eligibility criteria for each trial before applying, as some trials may only be open to patients with certain characteristics or medical histories.

Alternative and Complementary Therapies for Acral Lentiginous Melanoma

While there is no cure for acral lentiginous melanoma, various alternative and complementary therapies are sometimes used to manage the symptoms and side effects of this condition. It is important to note, however, that these therapies should not be used in place of medically approved treatments, and should always be discussed with a healthcare professional.

Naturopathy

Naturopathy is a branch of medicine that focuses on natural remedies and non-invasive treatments to promote healing and prevent disease. Naturopaths often use herbs, vitamins, and other supplements to support the body’s natural healing processes. While there is little scientific evidence to support the use of naturopathy in treating acral lentiginous melanoma specifically, some patients report that certain naturopathic treatments have helped to alleviate symptoms such as pain and fatigue.

Acupuncture

Acupuncture is a traditional Chinese medicine technique that involves inserting needles into specific points on the body to promote healing and relieve pain. Some patients with acral lentiginous melanoma find that acupuncture helps to relieve symptoms such as nausea and anxiety. While there is limited scientific evidence to support the use of acupuncture in managing the symptoms of this condition, many people find it to be a safe and effective alternative therapy.

Massage therapy

Massage therapy involves the manipulation of soft tissues in the body to help reduce pain and promote relaxation. Some patients with acral lentiginous melanoma find that massage therapy helps to relieve symptoms such as muscle tension and insomnia. While there is little scientific evidence to support the use of massage therapy in managing the symptoms of this condition, many people find it to be a soothing and relaxing therapy that can improve overall well-being.

Resources for Acral Lentiginous Melanoma Patients and Caregivers

Being diagnosed with acral lentiginous melanoma can be overwhelming, but it’s important to know that you are not alone. There are various resources available to help you navigate through this experience and provide you with the support and information you need. Here are some resources that may be helpful:

Support Groups

Support groups can be a valuable resource for patients with acral lentiginous melanoma and their caregivers. These groups provide an opportunity to connect with others who are going through similar experiences, share information and advice, and offer emotional support. Here are some support groups that you may find helpful:

Name of Support Group Description Contact Information
American Melanoma Foundation The American Melanoma Foundation is a non-profit organization that provides support, education, and advocacy for patients and families affected by melanoma. www.aimatmelanoma.org
Melanoma Research Foundation The Melanoma Research Foundation is a non-profit organization that offers educational resources, connects patients and caregivers with clinical trials and support groups, and advocates for melanoma research funding. www.melanoma.org
Melanoma Patients Information Page The Melanoma Patients Information Page is an online community that provides support, information, and resources for patients and caregivers affected by melanoma. www.mpip.org

Online Communities

Online communities can be a convenient way to connect with others and access information and support from the comfort of your own home. Here are some online communities that may be helpful:

Informational Websites

There are many websites available that provide information on acral lentiginous melanoma, including its diagnosis, treatment, and prevention. Here are some websites that provide reliable and helpful information:

Website Description URL
American Academy of Dermatology The American Academy of Dermatology offers information on various skin conditions, including acral lentiginous melanoma, its diagnosis, and treatment options. www.aad.org
National Cancer Institute The National Cancer Institute provides information on cancer, including acral lentiginous melanoma, its diagnosis, and available treatment options. www.cancer.gov
Melanoma Research Alliance The Melanoma Research Alliance funds research into the causes and treatment of melanoma and provides educational resources for patients and caregivers. www.curemelanoma.org

Remember that it’s important to discuss any questions or concerns you may have with your healthcare provider. They can provide you with personalized advice and guidance based on your specific situation.

Frequently Asked Questions about Acral Lentiginous Melanoma

Here are some of the most common questions people have about acral lentiginous melanoma, a rare but aggressive type of skin cancer that primarily affects the hands, feet, and nails.

What is acral lentiginous melanoma?

Acral lentiginous melanoma is a type of skin cancer that develops from the melanocytes, the cells that produce melanin, the pigment that gives color to the skin, hair, and eyes. It is a rare form of melanoma that primarily affects the palms of the hands, soles of the feet, and the nails, and is often misdiagnosed due to its atypical presentation.

What are the signs and symptoms of acral lentiginous melanoma?

The most common signs of acral lentiginous melanoma are new or changing pigmented lesions on the hands, feet, or nails. These lesions may also present as non-healing sores, or changes in the color and texture of the skin or nail. In some cases, the melanoma may also cause itching or bleeding.

How is acral lentiginous melanoma diagnosed?

Diagnosis of acral lentiginous melanoma usually involves a biopsy of the affected area. Dermoscopy, a technique in which a magnifying instrument is used to examine the skin, may also be used to aid in the diagnosis. Imaging tests such as CT scans or MRIs may be used to determine the extent of the disease once a diagnosis is confirmed.

What are the treatment options for acral lentiginous melanoma?

Treatment for acral lentiginous melanoma depends on the stage and location of the disease. Surgery is the primary treatment option for localized disease, while radiation therapy, immunotherapy, and chemotherapy may be used for advanced or metastatic disease. A personalized approach to treatment is often necessary, and should take into account the individual needs and preferences of each patient.

What is the prognosis for someone with acral lentiginous melanoma?

The prognosis for acral lentiginous melanoma depends on the stage of the disease at the time of diagnosis. Early stage disease has a higher chance of cure, while advanced or metastatic disease is more difficult to treat and has a lower five-year survival rate. Regular follow-up with a healthcare provider is crucial to monitor for recurrence.

Can acral lentiginous melanoma be prevented?

The best way to prevent acral lentiginous melanoma is to protect the skin from UV radiation, avoid known risk factors, and perform regular self-examinations for any new or changing lesions. This is particularly important for individuals with darker skin tones, as they may be at higher risk for this type of melanoma.

Meet the Author
Brio-Medical, Scottsdale AZ, is a natural, holistic, and integrative expert in the cancer field. He is the medical director at Brio Medical, a holistic, integrative cancer healing center in Scottsdale, Arizona. Brio-Medical received his Bachelor of Arts from Louisiana Tech University and his Doctor of Medicine from LSU Health Sciences Center. He is Board Certified in Obstetrics and Gynecology and served as the Chief Resident in Obstetrics and Gynecology at the University of Tennessee. Brio-Medical is a Fellow in Functional and Regenerative Medicine, is a medical Advisor for NEO7 Bioscience and has been named as the President of the North American Society of Laser Therapy Applications (NASLTA).

Related Posts

Ozone Non-Invasive Cancer Therapy Explained

By Brio-Medical, Scottsdale AZ | January 5, 2024

Welcome to our comprehensive guide on ozone non-invasive cancer therapy. In this article, we will explore the potential benefits, the lack of human studies, and […]

Exploring Cancer Treatments Beyond Chemo Options

By Brio-Medical, Scottsdale AZ | January 5, 2024

Chemotherapy has long been the standard treatment for cancer, but its efficacy comes with a cost – severe side effects that can significantly impact a […]

Curcumin Transdermal Patch for Skin Cancer Relief

By Brio-Medical, Scottsdale AZ | January 3, 2024

At Our Wellness Center, we are dedicated to providing innovative and effective solutions for skin cancer treatment. In recent years, curcumin, the active component of […]

Vitamin C Oral Supplement & Non-Hodgkin’s Lymphoma Care

By Brio-Medical, Scottsdale AZ | January 3, 2024

Vitamin C is a potential oral supplement for Non-Hodgkin’s Lymphoma patients to support standard treatments. Studies have shown that vitamin C has various therapeutic effects […]

Resveratrol Integrative Cancer Support Insights

By Brio-Medical, Scottsdale AZ | January 3, 2024

Welcome to our comprehensive guide on resveratrol integrative cancer support. In this article, we will explore the potential benefits and limitations of resveratrol, a polyphenolic […]

Exploring Red Light Therapy for Brain Tumors

By Brio-Medical, Scottsdale AZ | January 3, 2024

At the intersection of cutting-edge technology and medical innovation, red light therapy is emerging as a potential treatment for brain tumors. By harnessing the power […]

Posted in

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top